Sort   by:  
 Page size 
UnknownAbsolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.
Not available
S-EPMC3530689 | biostudies-literature
UnknownTumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.
Not available
S-EPMC6608613 | biostudies-literature
UnknownInference and validation of predictive gene networks from biomedical literature and gene expression data.
Not available
S-EPMC4119824 | biostudies-literature
UnknownAdiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis.
Not available
S-EPMC12682385 | biostudies-literature
UnknownGermline-activating mutations in PIK3CD compromise B cell development and function.
Not available
S-EPMC6080914 | biostudies-literature
UnknownRISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Not available
S-EPMC7248089 | biostudies-literature
UnknownActivating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells.
Not available
S-EPMC6612302 | biostudies-literature
UnknownPrognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
Not available
S-EPMC8408862 | biostudies-literature
UnknownAdjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Not available
S-EPMC8191233 | biostudies-literature
UnknownZIC1 is a context-dependent medulloblastoma driver in the rhombic lip.
Not available
S-EPMC11735403 | biostudies-literature
Sort   by:  
 Page size